# Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

> **NCT07696962** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Xeno Holdings (US), LLC dba ChoironeX** · enrollment: 4 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **BIOLOGICAL:** ChoironeX GalKO Porcine Thymokidney

## Key facts

- **NCT ID:** NCT07696962
- **Lead sponsor:** Xeno Holdings (US), LLC dba ChoironeX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-05-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2026-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696962, "Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*